From the Department of Neurology (M.N.U., H.A., G.S.), University of Rochester, NY.
Department of Imaging Sciences (M.T., G.S.), University of Rochester, NY.
Hypertension. 2021 Mar 3;77(3):751-758. doi: 10.1161/HYPERTENSIONAHA.120.15242. Epub 2021 Feb 10.
Primary hypertension in youth and young adulthood is associated with decreased neurocognitive test performance both in midlife and during youth itself, leading to concern of subsequent cognitive decline and dementia in later life. The early vascular effects of hypertension in youth are likely involved in the pathogenesis of hypertensive target organ damage to the brain, but the potential impact of antihypertensive treatment from youth on subsequent cognitive health is not known. This review will highlight the need to answer the question of whether treatment of hypertension from early in life would slow cognitive decline in adulthood, and will then outline, for the nonneurologist, magnetic resonance imaging techniques potentially useful in the study of the pathogenesis of decreased cognition in hypertensive youth and for use as potential biomarkers for early antihypertensive treatment interventions.
青年和成年早期的原发性高血压与中年和青年期自身的神经认知测试表现下降有关,这让人担心以后的认知能力下降和老年痴呆症。高血压在青年时期的早期血管效应可能与高血压靶器官对大脑的损害的发病机制有关,但从青年开始抗高血压治疗对以后认知健康的潜在影响尚不清楚。这篇综述将强调需要回答的问题是,从生命早期开始治疗高血压是否会减缓成年后的认知能力下降,然后将为非神经科医生概述磁共振成像技术,这些技术在研究高血压青年认知能力下降的发病机制以及作为早期抗高血压治疗干预的潜在生物标志物方面可能有用。